First- and second-line treatment strategies for hormone-receptor (HR)-positive HER2-negative metastatic breast cancer: A real-world study.
Basile D, Gerratana L, Corvaja C, Pelizzari G, Franceschin G, Bertoli E, Palmero L, Zara D, Alberti M, Buriolla S, Da Ros L, Bonotto M, Mansutti M, Spazzapan S, Cinausero M, Minisini AM, Fasola G, Puglisi F.
Basile D, et al. Among authors: puglisi f.
Breast. 2021 Jun;57:104-112. doi: 10.1016/j.breast.2021.02.015. Epub 2021 Mar 12.
Breast. 2021.
PMID: 33812267
Free PMC article.